# Clustering Approach 5 : MRNASEQ_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0429209381235435	Range of duration = 1.02 to 98.76, nDeath = 44, nCensor = 37
2	AGE	ANOVA	0.00656649031965313	Range of values = 18 to 87, Mean = 55.9793, StdDev = 16.076
3	PRIMARY.SITE.OF.DISEASE	Fisher's exact test	1.60403394475547e-06	nTypes = 2 (REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 33/112
4	GENDER	Fisher's exact test	0.70312838763654	nTypes = 2 (FEMALE/MALE), nPatients = 51/94
5	DISTANT.METASTASIS	Chi-square test	0.782027188789543	nTypes = 5 (M0/M1/M1A/M1B/M1C), nPatients = 126/1/2/2/1, nMissing = 13
6	LYMPH.NODE.METASTASIS	Chi-square test	0.624789842977337	nTypes = 10 (N0/N1/N1A/N1B/N2/N2A/N2B/N2C/N3/NX), nPatients = 77/2/5/12/1/4/10/4/16/2, nMissing = 12
7	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 145
8	NEOPLASM.DISEASESTAGE	Chi-square test	0.0265441247367938	nTypes = 13 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE IIC/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/16/8/13/17/7/8/4/8/4/15/21/4, nMissing = 19